FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation

Publisher： John Wiley & Sons Inc

E-ISSN： 1582-4934|19|7|1557-1568

ISSN： 1582-1838

Source： Journal of Cellular and Molecular Medicine, Vol.19, Iss.7, 2015-07, pp. : 1557-1568

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic kidney disease with comorbid cardiac dysfunction exacerbates cardiac and renal damage

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 1, 2018-01 ,pp. : 628-645

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Aza resveratrol–chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 3, 2018-03 ,pp. : 1931-1943

John Wiley & Sons Inc

Access to resources Recommend Favorite

Irisin inhibits high glucose‐induced endothelial‐to‐mesenchymal transition and exerts a dose‐dependent bidirectional effect on diabetic cardiomyopathy

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 2, 2018-02 ,pp. : 808-822

John Wiley & Sons Inc

Access to resources Recommend Favorite

Investigating the cardiac pathology of SCO2‐mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell–derived cardiomyocytes

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 2, 2018-02 ,pp. : 913-925

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lin28a protects against cardiac ischaemia/reperfusion injury in diabetic mice through the insulin‐PI3K‐mTOR pathway

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 6, 2015-06 ,pp. : 1174-1182

John Wiley & Sons Inc

Access to resources Recommend Favorite